Trial intelligence / Profile preview

Lot Consistency of DTaP-IPV-Hep B-PRP~T Vaccine in Mexican Infants

NCT00404651Phase 3Completed

Sponsor
Sanofi
Start
Nov 2006
Primary completion
Apr 2008
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Sanofi. Started Nov 2006; status: completed.

02

Drugs

hexaxim
03

Conditions

diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis

Beyond the preview

Go deeper on NCT00404651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00404651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call